Archive for the ‘Technology Stocks’ Category

MIPS, APPY, RFMD, SHMN – Buzz Stocks With Big Gains This Week

Friday, October 29th, 2010

Several of this week’s Buzz Stocks have had a string of days with solid gains:

MIPS Technologies, Inc. (Nasdaq: MIPS) – Shares of MIPS Technologies increased almost 24 percent from Monday’s closing price in morning trading on Tuesday after the chip maker announced first quarter profit of $7.6 million, or 16 cents per share, compared with $595,000, or a penny per share, a year earlier. Shares closed on Tuesday at $14.12, after rallying as high as $14.18. The next day, shares spiked to $14.65, before closing at $14.34. Shares of MIPS Technologies have are up about 40 percent since Monday.

AspenBio Pharma, Inc. (Nasdaq: APPY) – Shares of diagnostic products maker, AspenBio Pharma, Inc. (Nasdaq: APPY) were up as much as 71 percent from Monday’s closing price, in morning trading on Tuesday after the company announced that it initiated manufacturing on its AppyScore™ cassette-based test system, and added personnel to handle its clinical, regulatory and commercial planning efforts. Shares traded as high as 98 cents, before closing at 71 cents on Tuesday. Shares traded between 80 cents 61 cents on Wednesday and Thursday, and were trading at 69 cents in mid-day trading on Friday. Shares of AspenBio Pharma, Inc. are up about 86 percent since Monday.

RF Micro Devices, Inc. (Nasdaq: RFMD) – Shares of RFMD were up 13 percent in morning trading on Wednesday after the company posted revenue of $285.8 million, and EPS of 19 cents for its fiscal second quarter ended October 2. Analysts on average expected EPS of 16 cents, on revenue of $275.9 million. Since then, shares have continually moved higher, trading as high as $7.45 on Thursday. At mid-day Friday, shares of RFMD were trading at $7.39, up about 11 percent since Monday.

SOHM, Inc. (Pink Sheets: SHMN) – The generic drug maker had several news releases this week announcing its intent to capitalize on the market opportunity in India for the company’s products. On Thursday,SOHM announced the addition of six new generic pharmaceutical products targeting asthma and respiratory disease. Shares of SOHM rallied as high as 9 cents on Thursday, before closing at 6 cents per share. Trading volume on Thursday was 10.5 million shares, a significant increase over SOHM’s average three-month trading volume of 165,398 shares. Shares of SHMN are up approximately 60 percent since Monday.

Pervasip Corp. (PVSP), SOHM, Inc. (SHMN) – Today’s Top OTC Buzz Stocks

Thursday, October 28th, 2010

Shares of Pervasip Corp. (OTCBB: PVSP) were up 40 percent from Monday’s closing price, on Tuesday after the company announced that its wholly-owned subsidiary, VoX Communications Corp. released a new Voice over IP (VoIP) application for Android®. Unlike other VoIP applications that require Wi-Fi, the Android application developed by Vox Communications, and Nimbuzz, also runs on 3G networks.  Pervasip is a partner in Nimbuzz’s SIP Premium Affiliate Partner Program that was established to enable 3rd party SIP technology providers, like Pervasip, to offer their services across the Nimbuzz open, universal communications platform. “We are very excited to become the first US-based premier partner to integrate our cloud-based SIP mobile calling software with Nimbuzz,” said Pervasip’s Chief Information Officer, Mark Richards in a statement. “A smooth and easy download, people appreciate having a phone line from VoX, which gives them a second phone number, a second voice mail box and low-priced VoIP calling plans that run over both the 3G and WiFi data networks. We see reports of daily sales for approximately 200,000 Android phones.” Every Nimbuzz Android download will also feature the VoX logo as the second icon on the SIP providers list within the installed Nimbuzz application. Shares of Pervasip are down roughly 60 percent over the past three months.

Shares of SOHM, Inc. (Pink Sheets: SOHM) were up more than 42 percent from Monday’s closing price on Tuesday on volume 10,568,984. SOHM shares’ average three month trading volume is 165,398. The generic drug maker today announced the addition of six new generic pharmaceutical products targeting asthma and respiratory disease. “”The market for respiratory products in India is huge,” stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. in a written statement. According to a recent news release, India’s respiratory drug market size is approximately $600 million annually. Shares of SOHM, Inc. are up about 9 percent over the past three months.

Microsoft Corp. (MSFT) – Buzz Stock of the Day

Thursday, October 28th, 2010

Software giant Microsoft Corp. (Nasdaq: MSFT) reported strong profit and sales growth in its first fiscal quarter, driven largely by sales of its flagship Windows and Office software and the launch of the latest blockbuster Halo video game.

For its first fiscal quarter ended September 30, 2010, Microsoft reported EPS of 62 cents. Analysts on average were expecting earnings of 55 cents per share, according to Thomson Reuters. Operating income, and  net income a the quarter were $7.12 billion, $5.41 billion, which represented increases of 59 percent and 51 percent  respectively, when compared with the prior year period. Sales increased 25 percent to $16.2 billion, ahead of analysts’ $15.8 billion average estimates.
[–quote–]
“This was an exceptional quarter, combining solid enterprise growth and continued strong consumer demand for Office 2010, Windows 7, and Xbox 360 consoles and games,” said Peter Klein, chief financial officer at Microsoft in a statement. “Our ability to grow revenue while continuing to control costs allowed us to deliver another quarter of year-over-year margin expansion.”

Among the highlights were a 15 percent sales growth in Microsoft’s Office 2010 software, and a 38 percent increase in sales of Microsoft’s Xbox 360 game console.

“We ended up in this great sweet spot in business spending that was re-emerging after the downturn,” Microsoft’s general manager of investor relations, Bill Koefoed, said in an interview. Increased business spending “aligned just perfectly” with Microsoft’s product launches, according to Koefoed.

Revenue from Microsoft’s Windows division increased 66 percent to $4.8 billion. Office and other business software brought in $5.1 billion, a 14 percent jump, over last year. The group that makes server software reported a 12 percent increase in revenue to $4 billion. Microsoft’s online revenue, which comes primarily from search advertising,  was up  8 percent to $527 million.

The company reaffirmed its operating expense guidance of $26.9 billion to $27.3 billion for the full year ending June 30, 2011.

Notable Nasdaq Gainers – BSDM, LOJN, SIMG, RFMD

Wednesday, October 27th, 2010

Shares of BSD Medical Corporation (Nasdaq: BSDM) were up as much as 25 percent from Tuesday’s closing price of $3.94 per share, on Wednesday. Shares traded as high as $4.95 per share with nearly double the company’s average three-month volume. BSD Medical won the Frost & Sullivan “Technology Innovation of the Year Award” in 2005 for its BSD-2000 system. But its biggest money generator is the MicroThermX. BSDM’s patented “phased-array” technology generates heat allows doctors to kill massive clusters of cancer cells. Shares BSDM are up roughly 280 percent since the FDA granted the company clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue in August of this year.

Shares of JoJack Corp. (Nasdaq: LOJN) were up more than 34 percent from Tuesday’s closing price, in morning trading on Wednesday on nearly 7x the company’s average three month volume. The car recovery technology developer recently reported a 47 percent increase in third quarter international sales. The company also reported net income of $2.7 million, or 15 cents per share, up from a loss of $13.4 million, or 78 cents per share a year earlier. Consolidated third quarter revenue climbed 7 percent to $38.5 million, from a year ago. Shares of LOJN are up about 47 percent over the past three months.

Shares of chip maker, Silicon Image, Inc. (Nasdaq: SIMG) were up as much as 44 percent from Tuesday’s closing price, in morning trading on Wednesday. Shares traded as high as $6.57, up from Tuesday’s closing price of $4.55. Silicon Image earned $9.5 million, or 12 cents per share, compared to a net loss of $15.5 million, or 21 cents per share a year ago. Excluding items, the company earned 18 cents per share. Third quarter revenue increased 63 percent to $60.5 million, which included a $7.5 million royalty revenue catch-up. Analysts on average, expected the company to post earnings of a nickel per share (excluding items), on revenue of $49 million. The company sees fourth quarter revenue in the range of $46 million to $48 million, above analysts’ estimates of $45.4 million.

RF Micro Devices, Inc. (Nasdaq: RFMD) was up 13 percent from Tuesday’s closing price, in morning trading on Wednesday after the company posted revenue of $285.8 million, and EPS of 19 cents for its fiscal second quarter ended October 2. Analysts on average expected EPS of 16 cents, on revenue of $275.9 million. “On the strength of new product launches and diversification efforts, we continue to reduce our exposure at our largest customer while sales to all other customers grew year-over-year by approximately 53%,” said RFMD’s CEO Bob Bruggeworth in a conference call. “s a result, RFMD delivered our sixth consecutive quarter of expanding operating income with the September quarter representing another company record.” Shares of RFMD are up as much as 61 percent over the past three months.

AspenBio Pharma, Inc. (APPY) – Buzz Stock of the Day

Tuesday, October 26th, 2010

Shares of diagnostic products maker, AspenBio Pharma, Inc. (Nasdaq: APPY) were up as much as 71 percent from Monday’s closing price, in morning trading on Tuesday after the company announced that it initiated manufacturing on its AppyScore™ cassette-based test system, and added personnel to handle its clinical, regulatory and commercial planning efforts.

“Aspen has made significant progress advancing the AppyScore cassette-based test and we are excited to put the test in the hands of actual hospital users for feedback as we proceed towards our pivotal clinical trial,” said Steve Lundy, President and Chief Executive Officer in a statement.
[–quote–]
AppyScore™ is a rapid, blood-based test designed to assist doctors in assessing the low risk population of emergency room patients suspected of having acute appendicitis when presenting with abdominal pain.

According to AspenBio’s Web site, up to 18% of patients are misdiagnosed and sent home with appendicitis; 8 – 10% of surgeries remove a normal appendix; women are more difficult to diagnose than men and the negative appendectomy rate is significantly higher in women; an estimated 1 million patients present annually with a low risk for acute appendicitis and are exposed to unnecessary CT scan radiation—a potentially significant health risk.

The Colorado-based company also appointed Michael Wandell, PharmD to lead its human diagnostic products’ clinical and regulatory strategy, and Erik Miller to head the company’s commercial planning efforts, including pre-clinical field testing of the AppyScore system.

Shares of AspenBio Pharma, Inc. are up about 44 percent since October 1.